Human cytomegalovirus induces MMP-1 and MMP-3 expression in aortic smooth muscle cells

Acta Microbiologica et Immunologica Hungarica

Volumn 58, Issue 4, 2011, Pages 303-317

  Prochnau, Dirk ^a   Lehmann, Marc ^b,c   Straube, Eberhard ^a   Figulla, Hans ^a   Rödel, Jürgen ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b SIRS Lab GmbH   (Germany)

^c Moldiax GmbH   (Germany)

Author keywords

aortic SMC; atherosclerosis; CMV; MMP

Indexed keywords

ALPHA CHEMOKINE; APOPTOSIS RELATED FACTOR; BETA CHEMOKINE; CELL ADHESION MOLECULE; INTERSTITIAL COLLAGENASE; STROMELYSIN; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DNA MICROARRAY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME IMMUNOASSAY; ENZYME INDUCTION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE PRODUCT; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE MICROARRAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VIRUS STRAIN;

HUMAN HERPESVIRUS 5;

EID: 84855441314     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.58.2011.4.7     Document Type: Article

References (34)

1. Ross, R.: Atherosclerosis-aninflammatorydisease. N. Engl. J. Med. 340,115-126 (1999).
2. Hansson, G. K.: Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695 (2005).
3. Melnick, J. L., Petrie, B. L., Dreesman, G. R., Burek, J., Mc Collum, C. H., De Bakey, M. E.: Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 2, 644-647 (1983). (Pubitemid 13003484)
4. Merigan, T. C., Renlund, D. G., Keay, S., Bristow, M. R., Starnes, V., O'Connell, J. B., Resta, S., Dunn, D., Gamberg, P., Ratkovec, R. M. et al.: A controlled trial ofganciclovir to prevent cytomegalovirus disease after heart transplantation. N. Engl. J. Med. 326, 1182-1186 (1992).
5. Speir, E., Modali, R., Huang, E. S., Leon, M. B., Shawl, F., Finkel, T., Epstein, S. E.: Poten-tial role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265, 391-394 (1994). (Pubitemid 24259971)
6. Roberts, E. T., Haan, M. N., Dowd, J. B., Aiello, A. E.: Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am. J. Epidemiol. 172, 363-371 (2010).
7. Vliegen, I., Duijvestijn, A., Grauls, G., Herngreen, S., Bruggeman, C., Stassen, F.: Cytomegalovirus infection aggravates atherogenesis in apo E knockout mice by both local and systemic immune activation. Microbes Infect. 6, 17-24 (2004). (Pubitemid 38114817)
8. Soule, J. L., Streblow, D. N., Andoh, T. F., Kreklywich, C. N., Orloff, S. L.: Cytomegalovirus accelerates chronic allograft nephropathy in a rat renal transplant model with associated provocative chemokine profiles. Transplant. Proc. 38, 3214-3220 (2006). (Pubitemid 44908561)
9. Streblow, D. N., Kreklywich, C., Yin, Q., De La Melena, V. T., Corless, C. L., Smith, P. A., Brakebill, C., Cook, J. W., Vink, C., Bruggeman, C. A., Nelson, J. A., Orloff, S. L.: Cytomegalovirus-mediated upregulation ofchemokine expression correlates with the accel-eration ofchronic rejection in rat heart transplants. J. Virol. 77, 2182-2194 (2003). (Pubitemid 36110031)
10. Tikkanen, J., Kallio, E., Pulkkinen, V., Bruggeman, C., Koskinen, P., Lemstrom, K.: Cyto-megalovirus infection-enhanced chronic rejection in the rat is prevented by antiviral pro-phylaxis. Transplant. Proc. 33, 1801 (2001).
11. Zeng, H., Waldman, W. J., Yin, D. P., Knight, D. A., Shen, J., Ma, L., Meister, G. T., Chong, A. S., Williams, J. W.: Mechanistic study ofmalononitrileamide FK778 in cardiac trans-plantation and CMV infection in rats. Transplantation 79, 17-22 (2005). (Pubitemid 40139995)
12. Lemstrom, K., Koskinen, P., Krogerus, L., Daemen, M., Bruggeman, C., Hayry, P.: Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening inrat cardiac allografts aftercytomegalovirus infection. Circulation92,2594-2604 (1995).
13. Lemstrom, K. B., Bruning, J. H., Bruggeman, C. A., Lautenschlager, I. T., Hayry, P. J.: Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thicken-ing of rat aortic allografts. J. Clin. Invest. 92, 549-558 (1993). (Pubitemid 23262370)
14. Gerna, G., Baldanti, F., Revello, M. G.: Pathogenesis of human cytomegalovirus infection andcellulartargets. Hum. Immunol. 65, 381-386 (2004). (Pubitemid 38686760)
15. Reeves, M. B., Coleman, H., Chadderton, J., Goddard, M., Sissons, J. G., Sinclair, J. H.: Vascular endothelial and smooth muscle cells are unlikely to be major sites oflatency of hu-man cytomegalovirus invivo. J. Gen. Virol. 85, 3337-3341 (2004). (Pubitemid 39445452)
16. Evers, D. L., Wang, X., Huang, E. S.: Cellular stress and signal transduction responses to human cytomegalovirus infection. Microbes Infect. 6, 1084-1093 (2004). (Pubitemid 39233681)
17. Bouis, D., Kusumanto, Y., Meijer, C., Mulder, N. H., Hospers, G. A.: A review onpro- and anti-angiogenic factors as targets of clinical intervention. Pharmacol. Res. 53, 89-103 (2006). (Pubitemid 43003475)
18. Clinton, S. K., Libby, P.: Cytokines andgrowthfactors inatherogenesis. Arch. Pathol. Lab. Med. 116, 1292-1300 (1992).
19. Baumert, J., Schmidt, K. H., Eitner, A., Straube, E., Rodel, J.: Host cell cytokines induced by Chlamydiapneumoniae decrease the expression ofinterstitial collagens and fibronectin in fibroblasts. Infect. Immun. 77, 867-876 (2009).
20. Huber, W., von Heydebreck, A., Sueltmann, H., Poustka, A., Vingron, M.: Parameter esti-mation for the calibration and variance stabilization of microarray data. Stat. Appl. Genet. Mol. Biol. 2, Article 3 (2003).
21. Rodel, J., Prochnau, D., Prager, K., Baumert, J., Schmidt, K. H., Straube, E.: Chlamydia pneumoniae decreases smooth muscle cell proliferation through induction of prostaglandin E2 synthesis. Infect. Immun. 72, 4900-4904 (2004). (Pubitemid 38989356)
22. Gordon, D., Reidy, M. A., Benditt, E. P., Schwartz, S. M.: Cell proliferation in human coro-nary arteries. Proc. Natl Acad. Sci. U S A 87, 4600-4604 (1990). (Pubitemid 20204150)
23. Libby, P., Ridker, P. M., Maseri, A.: Inflammation and atherosclerosis. Circulation 105, 1135-1143 (2002). (Pubitemid 34212626)
24. Dumortier, J., Streblow, D. N., Moses, A. V., Jacobs, J. M., Kreklywich, C. N., Camp, D., Smith, R. D., Orloff, S. L., Nelson, J. A.: Human cytomegalovirus secretome contains fac-tors that induce angiogenesis and wound healing. J. Virol. 82, 6524-6535 (2008). (Pubitemid 351875129)
25. Renne, R., Barry, C., Dittmer, D., Compitello, N., Brown, P. O., Ganem, D.: Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sar-coma-associated herpesvirus. J. Virol. 75, 458-468 (2001).
26. Stoneman, V. E., Bennett, M. R.: Role of apoptosis in atherosclerosis and its therapeutic im-plications. Clin. Sci. (Lond). 107, 343-354 (2004). (Pubitemid 39389301)
27. Jang, J. Y., Jeon, Y. K., Choi, Y., Kim, C. W.: Short-hairpin RNA-induced suppression of adenine nucleotide translocase-2 in breast cancer cells restores their susceptibility to TRAIL-induced apoptosis by activating JNK and modulating TRAIL receptor expression. Mol. Cancer 9, 262 (2010).
28. Shen, Y. H., Utama, B., Wang, J., Raveendran, M., Senthil, D., Waldman, W. J., Belcher, J. D., Vercellotti, G., Martin, D., Mitchelle, B. M., Wang, X. L.: Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signalingpathways. Circ. Res. 94, 1310-1317 (2004). (Pubitemid 38724476)
29. Reboredo, M., Greaves, R. F., Hahn, G.: Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication. J. Gen. Virol. 85, 3555-3567 (2004). (Pubitemid 39591862)
30. Penfold, M. E., Dairaghi, D. J., Duke, G M., Saederup, N., Mocarski, E. S., Kemble, G W., Schall, T. J.: Cytomegalovirus encodes apotent alpha chemokine. Proc. Natl. Acad. Sci. U S A 96, 9839-9844 (1999). (Pubitemid 29398819)
31. Newby, A. C.: Dual role ofmatrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 85, 1-31 (2005). (Pubitemid 40171256)
32. Román-García, P., Coto, E., Reguero, J. R., Cannata-Andía, J. B., Lozano, I., Avanzas, P., Morís, C., Rodríguez, I.: Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: A case-control study in a Spanish population. Coron. Artery Dis. 20, 383-386 (2009).
33. Clee, S. M.: A role for MMP-3 genetic variation in atherosclerosis susceptibility? Athero-sclerosis 208, 30-31 (2010).
34. Dargan, D. J., Jamieson, F. E., Mac Lean, J., Dolan, A., Addison, C., Mc Geoch, D. J.: The published DNA sequence of human cytomegalovirus strain AD169 lacks 929 base pairs af-fecting genes UL42 and UL43. J. Virol. 71, 9833-9836 (1997). (Pubitemid 27492439)